Literature DB >> 21300794

Tissue transglutaminase-mediated glutamine deamidation of beta-amyloid peptide increases peptide solubility, whereas enzymatic cross-linking and peptide fragmentation may serve as molecular triggers for rapid peptide aggregation.

Adrien W Schmid1, Enrico Condemi, Gabriele Tuchscherer, Diego Chiappe, Manfred Mutter, Horst Vogel, Marc Moniatte, Yury O Tsybin.   

Abstract

Tissue transglutaminase (TGase) has been implicated in a number of cellular processes and disease states, where the enzymatic actions of TGase may serve in both, cell survival and apoptosis. To date, the precise functional properties of TGase in cell survival or cell death mechanisms still remain elusive. TGase-mediated cross-linking has been reported to account for the formation of insoluble lesions in conformational diseases. We report here that TGase induces intramolecular cross-linking of β-amyloid peptide (Aβ), resulting in structural changes of monomeric Aβ. Using high resolution mass spectrometry (MS) of cross-linked Aβ peptides, we observed a shift in mass, which is, presumably associated with the loss of NH3 due to enzymatic transamidation activity and hence intramolecular peptide cross-linking. We have observed that a large population of Aβ monomers contained an 0.984 Da increase in mass at a glutamine residue, indicating that glutamine 15 serves as an indispensable substrate in TGase-mediated deamidation to glutamate 15. We provide strong analytical evidence on TGase-mediated Aβ peptide dimerization, through covalent intermolecular cross-linking and hence the formation of Aβ1-40 dimers. Our in depth analyses indicate that TGase-induced post-translational modifications of Aβ peptide may serve as an important seed for aggregation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300794      PMCID: PMC3069422          DOI: 10.1074/jbc.M110.176149

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain.

Authors:  Micha M M Wilhelmus; Sentini C S Grunberg; John G J M Bol; Anne-Marie van Dam; Jeroen J M Hoozemans; Annemieke J M Rozemuller; Benjamin Drukarch
Journal:  Brain Pathol       Date:  2008-07-31       Impact factor: 6.508

2.  Transglutaminase activity is increased in Alzheimer's disease brain.

Authors:  G V Johnson; T M Cox; J P Lockhart; M D Zinnerman; M L Miller; R E Powers
Journal:  Brain Res       Date:  1997-03-21       Impact factor: 3.252

3.  Oxidation of methionine 35 attenuates formation of amyloid beta -peptide 1-40 oligomers.

Authors:  Magnus Palmblad; Anita Westlind-Danielsson; Jonas Bergquist
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

4.  Glutamine deamidation: differentiation of glutamic acid and gamma-glutamic acid in peptides by electron capture dissociation.

Authors:  Xiaojuan Li; Cheng Lin; Peter B O'Connor
Journal:  Anal Chem       Date:  2010-05-01       Impact factor: 6.986

Review 5.  Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance.

Authors:  Carla Esposito; Ivana Caputo
Journal:  FEBS J       Date:  2005-02       Impact factor: 5.542

6.  Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase.

Authors:  K Ikura; K Takahata; R Sasaki
Journal:  FEBS Lett       Date:  1993-07-12       Impact factor: 4.124

7.  Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease.

Authors:  G Andringa; K Y Lam; M Chegary; X Wang; T N Chase; M C Bennett
Journal:  FASEB J       Date:  2004-03-04       Impact factor: 5.191

8.  Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers.

Authors:  D J Selkoe; C Abraham; Y Ihara
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

9.  Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease.

Authors:  Takekazu Kubo; Yoshihiro Kumagae; Carol A Miller; Isao Kaneko
Journal:  J Neuropathol Exp Neurol       Date:  2003-03       Impact factor: 3.685

10.  Tissue transglutaminase catalyzes the deamidation of glutamines in lens betaB(2)- and betaB(3)-crystallins.

Authors:  Sandor Boros; Phillip A Wilmarth; Bram Kamps; Wilfried W de Jong; Hans Bloemendal; Kirsten Lampi; Wilbert C Boelens
Journal:  Exp Eye Res       Date:  2007-11-29       Impact factor: 3.467

View more
  8 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  Specific mutation of transglutaminase gene from Streptomyces hygroscopicus H197 and characterization of microbial transglutaminase.

Authors:  Wenjie Wan; Donglan He; Zhijun Xue; Zewen Zhang
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

3.  Transglutaminase 2-dependent deamidation of glyceraldehyde-3-phosphate dehydrogenase promotes trophoblastic cell fusion.

Authors:  Kaori Iwai; Yukinao Shibukawa; Natsuko Yamazaki; Yoshinao Wada
Journal:  J Biol Chem       Date:  2013-12-27       Impact factor: 5.157

4.  Optimised methods (SDS/PAGE and LC-MS) reveal deamidation in all examined transglutaminase-mediated reactions.

Authors:  Éva Sivadó; Meddy El Alaoui; Robert Kiraly; László Fesüs; Frédéric Delolme; Adeline Page; Saïd El Alaoui
Journal:  FEBS Open Bio       Date:  2019-01-18       Impact factor: 2.693

5.  The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer's Disease.

Authors:  Micha M M Wilhelmus; Elisa Tonoli; Clare Coveney; David J Boocock; Cornelis A M Jongenelen; John J P Brevé; Elisabetta A M Verderio; Benjamin Drukarch
Journal:  Cells       Date:  2022-01-24       Impact factor: 6.600

6.  Absence of tissue transglutaminase reduces amyloid-beta pathology in APP23 mice.

Authors:  Micha M M Wilhelmus; Osoul Chouchane; Maarten Loos; Cornelis A M Jongenelen; John J P Brevé; Allert Jonker; John G J M Bol; August B Smit; Benjamin Drukarch
Journal:  Neuropathol Appl Neurobiol       Date:  2022-02-23       Impact factor: 6.250

7.  Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models.

Authors:  Micha M M Wilhelmus; Mieke de Jager; August B Smit; Rolinka J van der Loo; Benjamin Drukarch
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

Review 8.  Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies.

Authors:  Mahesh Mohan; Chioma M Okeoma; Karol Sestak
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.